Global Bovine-based Collagen for Biomedical Applications Market Worth USD 2.26 Billion With a CAGR of 9.60% 

Some primary reasons influencing the market's growth include the rising frequency of the aforementioned ailments and diseases, the expanding usage of collagen products derived from cows in orthopedic and dental procedures, and ongoing research and development. Other important considerations are the rising need for collagen products made from cows to treat various illnesses and conditions, such as wound healing, dental therapy, gastric reflux, osteoarthritis, and rheumatoid arthritis.

Market Dynamics

High Demand for Bovine-Based Collagen to Treat a Variety of Diseases Drives the Global Market

Collagen-based products are safe for human health, especially for the elderly, as has long been known. Clinical studies have examined the effects of collagen therapy on skin regeneration, bone defects, sarcopenia, wound healing, dental therapy, gastroesophageal reflux, osteoarthritis, and rheumatoid arthritis. According to a report titled "A Review of the Effects of Collagen Treatment in Clinical Studies," published by Multidisciplinary Digital Publishing Institute in November 2021, collagen therapies significantly impact clinical studies. Collagen deficiency may be associated with the comorbidity of the disorders above, particularly COVID-19, in a patient, and collagen therapy may be a suitable option.

According to a study titled "Bovine-Based Collagen Dressings in Wound Care Management," published in the "Journal of Pharmaceutical Research International" in December 2020, collagen aids in the debridement of contaminated tissues. It promotes natural development in treating acute and chronic wounds such as cuts, burns, and ulcers linked to other illnesses. The use of collagen biomaterials derived from cows is becoming more common to reduce undesirable results, such as infection, discomfort, and other harmful effects. Due to its applications in developing markets, such as acute and chronic wound care, which will further fuel market expansion, it is projected that bovine-based collagen will be utilized more frequently in treating acute and chronic wounds.

Rising Demand for Dental and Orthopedic Surgeries Creates Tremendous Opportunities

Due to factors like the increased prevalence of orthopedic and dental disorders and the rising demand for bovine collagen to treat those conditions, this market is expected to grow. According to a study titled "What is the global prevalence of dental healthcare demands and unmet dental requirements among adolescents?" published in the journal "Evidence-Based Dentistry" in March 2021, the prevalence of dental healthcare needs across all categories of dental care was 49%. The majority of people (71%) reported needing periodontal therapy, followed by demands for available treatment (59%), orthodontic treatment (46%), and malocclusion treatment (39%).

Another factor expected to fuel market growth is the rising usage of collagen derived from cows in dental procedures. According to a paper titled "Nonsurgical Treatment of Peri-Implantitis: Case Series," published in "The multidisciplinary Digital Publishing Institute" in July 2020, peri-implantitis is one of the most common biological side effects of dental implants. There are various nonsurgical treatments to treat peri-implantitis, including topical antibiotics (doxycycline, lincomycin, and erythromycin), mechanical and chemical cleaning of the dental implant surface, and a minimally invasive regeneration technique using injections of bovine collagen

Regional Analysis 

North America is the most significant revenue contributor and is anticipated to grow at a CAGR of 8.95% over the projection period. The fundamental forces behind market growth include the rising demand for bovine-based collagen to treat a wide range of illnesses, the adoption of strategic initiatives by market players, and the rise in orthopedic issues in the United States. For instance, due to successful outcomes in the treatment of osteoarthritis, the market is growing in the United States (OA). Osteoarthritis is one of the most prevalent chronic conditions and a leading contributor to disability (OA). According to the National Public Health Agenda for Osteoarthritis 2020 Update by the Osteoarthritis Action Alliance, 32.5 million persons in the United States have osteoarthritis (OA), the most common kind of arthritis and a severe chronic condition impacting 1 in 7 adults.

Europe is anticipated to grow at a CAGR of 9.80%. The market in Germany is expected to grow due to crucial factors such as the implementation of strategic efforts by industry participants and the increased demand for bovine-based collagen to cure orthopedic diseases. For instance, the age- and sex-specific incidence of psoriatic arthritis (PsA) both showed a steady rise with advancing age until it peaked just before the age of 60 and then started to decline, according to a November 2021 article titled "Risk of psoriatic arthritis depending on age: analysis of data from 65 million people on statutory insurance in Germany." Women had a higher maximum value (40 per 100 000 py) than men (30 per 100 000 py). The incidence rate also tends to rise throughout the survey.

Key Highlights

• The global bovine-based collagen for biomedical applications was valued at USD 991.90 million in 2022. It is projected to reach USD 2,263.41 million by 2031, growing at a CAGR of 9.60% during the forecast period (2023-2031).
• Based on application, the global bovine-based collagen for biomedical applications market is bifurcated into bone graft substitutes, collagen-based scaffolds, hemostats, skin substitutes, cartilage repairs, and other applications. The bone graft substitutes segment is the highest contributor to the market and is estimated to boost at a CAGR of 10.40% during the forecast period.
• North America is the major revenue contributor and is expected to boost at a CAGR of 8.95% during the forecast period.

Market Segments

Global Bovine-based Collagen for Biomedical Application Market: Segmentation

By Applications

• Bone Graft Substitutes
• Collagen-based Scaffolds
• Hemostats
• Skin Substitutes
• Cartilage Repairs
• Other Applications

By Regions

• North America
• Europe
• Asia-Pacific
• LAMEA